Left Ventricular Dysfunction Post-surgical Patent Ductus Arteriosus Ligation in Children: Predictor Factors Analysis

Sponsor
South Valley University (Other)
Overall Status
Completed
CT.gov ID
NCT04018079
Collaborator
(none)
50
41

Study Details

Study Description

Brief Summary

Background:

PDA is viewed as a standout amongst the most widely recognized congenital heart defects in children and its closure is responsible for many hemodynamic changes that require intervention and care.

Methods:

A retrospective study included fifty children with isolated PDA treated by surgical ligation from June 2015 to June 2018. Their mean age was 15.78 ± 7.58 months and 72% were females. The LV dimensions and systolic function were assessed by two-dimensional echocardiography pre PDA ligation. The mean duct size was 4.08 ± 1.25 mm.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Methods:

    Study population Fifty children with PDA, for whom surgical PDA ligation was done from June 2015 to June 2018. All cases were operated in cardiothoracic surgery department and were followed up by cardiothoracic surgeons and paediatricians at cardiac surgery ICU, Qena University Hospital. Their mean age at intervention was 15.78 ± 7.58 months, body surface area (BSA) 0.43±0.03 and 32 (72%) were females. The mean duct diameter was 4.08 ± 1.25 mm. The study conforms to the ethical standards of the Helsinki Declaration and approval was obtained from the institutional ethics committee of Qena Faculty of Medicine.

    Surgical technique PDA ligation was performed under general anaesthesia after pre-operative anaesthetic evaluation. After single endotracheal tube anaesthesia induction; children were placed on the right lateral recumbent position fixed with adhesive plaster and a pad under the chest, the left arm raised above the head. A left mini-thoracotomy incision is done parallel to the medial border of the scapula and entrance to the thoracic cavity was via the third or fourth intercostal space. Cautiously, the ductus is identified and dissected carefully. Then it was doubly ligated with silk ligature (2/0 or 0). An intercostal tube inserted during operation and removed within 48 hours if no drainage presents.

    Descriptive statistical analysis Data were arranged and analyzed utilizing Version 20 of the SPSS program (Statistical Package for Social Sciences). Continuous variables were compared using the Student paired t-test and are expressed as mean values ± standard deviation. Pearson Chi-Square tests were used to detect differences among groups for categorical variables. The relationship between PDA size and changes in echocardiographic parameters was verified using the Pearson linear correlation and the linear regression analysis. P-value of <0.05 was considered of significance.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    50 participants
    Observational Model:
    Cohort
    Time Perspective:
    Other
    Official Title:
    Left Ventricular Dysfunction Post Surgical Patent Ductus Arteriosus Ligation in Children: Predictor Factors Analysis
    Actual Study Start Date :
    Jun 1, 2015
    Actual Primary Completion Date :
    Jun 30, 2018
    Actual Study Completion Date :
    Oct 30, 2018

    Outcome Measures

    Primary Outcome Measures

    1. Comparison between the echocardiographic changes before PDA ligation to the follow up changes at one day, one month and six months post PDA ligation. [echocardiography was done before PDA ligation; and follow up at one day, one month and six months post ligation.]

      the echocardiographic data included: The LV end-diastolic dimension (LVEDd) in mm, LV end-systolic dimension (LVESd) in mm, PDA size in mm, left atrial to aortic diameter ratio (LA/Ao ratio), EF % and FS %

    Secondary Outcome Measures

    1. identification of the preoperative predictor factors of LV dysfunction following PDA surgical ligation in children [all data were collected pre ligation; at one day, one month and six months post ligation]

      we classified our patients into two gatherings as indicated by FS % based on a definition of LV systolic dysfunction; group I with FS ≤ 29% and group II with FS > 29%.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    8 Months to 24 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • All cases had clinical as well as echocardiographic proof of hemodynamically critical PDA.
    Exclusion Criteria:
    • Patients with silent PDA.

    • irreversible pulmonary vascular disease.

    • those who had associated hemodynamically significant congenital heart disease (CHD).

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • South Valley University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Mohamed Abdel Bary Ahmed Ibrahim, Associate professor, South Valley University
    ClinicalTrials.gov Identifier:
    NCT04018079
    Other Study ID Numbers:
    • South Valley University 1513
    First Posted:
    Jul 12, 2019
    Last Update Posted:
    Jul 12, 2019
    Last Verified:
    Jul 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Mohamed Abdel Bary Ahmed Ibrahim, Associate professor, South Valley University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 12, 2019